产品详情
Targets
Target | Value |
---|---|
VEGFR3 | IC50: 125nM |
VEGFR2 | IC50: 160nM |
VEGFR1 | IC50: 170nM |
PDGFRα | IC50: 965nM |
c-Kit | IC50: 4330nM |
BTK | IC50: 9200nM |
PDGFRβ | IC50: 9850nM |
Tie-2 | IC50: 9900nM |
In vitro (25°C) | DMSO | 8 mg/mL (19.18 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 0.5% methylcellulose+0.2% Tween 80 | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.99 mL | 119.93 mL | 239.87 mL |
0.5 mM | 4.8 mL | 23.99 mL | 47.97 mL |
1 mM | 2.4 mL | 11.99 mL | 23.99 mL |
5 mM | 0.48 mL | 2.4 mL | 4.8 mL |
*The above data is based on the productmolecular weight 416.9. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10504 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 416.9 |
Formula | C20H21ClN4O4 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 286370-15-8 |
Synonyms | KRN633, KRN-633 |
SMILES | CCCNC(=O)NC1=C(C=C(C=C1)OC2=NC=NC3=CC(=C(C=C32)OC)OC)Cl |
产品标签
Product Questions
Product Questions
TSU-68 (Orantinib, SU6668)
TSU-68 (Orantinib,SU6668)在无细胞试验中具有8 nM的Ki对PDGFR自磷酸化的最大效力,但也强烈抑制Flk-1和FGFR1反磷酸…
Motesanib (AMG706)
Motesanib(AMG706)是一种多激酶抑制剂,可选择性靶向VEGF受体,血小板衍生的生长因子受体(PDGFRs)和Kit受体…
Imatinib (Gleevec)
Imatinib (Gleevec)是一种多靶点酪氨酸激酶抑制剂,抑制v-Abl、c-Kit和PDGFR的IC50分别为0.6,0.1和0.1 μM。
Vatalanib (PTK787) 2HCl
Vatalanib (PTK787) 2HCl是一种小分子蛋白激酶抑制剂,可抑制抑制所有已知VEGF受体以及血小板衍生的生长因子…
Buflomedil HCl
Buflomedil HCl是一种用于治疗外周血管疾病的血管活性剂。
Flumatinib mesylate
Flumatinib mesylate以时间和剂量依赖性的方式降低U266细胞中C-MYC,HIF-1a和VEGF的表达,因此甲磺酸氟马替尼可能…
Bibf1120 (Nintedanib)
Bibf1120 (Nintedanib)是一种新型的三联血管激酶抑制剂,可同时抑制三种生长因子受体:VEGFR,PDGF和FGFR。